1.Professional consulting service of Investigational new drug trials (Phase I-IV) and Cell therapy

2.Professional consulting service of Bioavailability (BA) and Bioequivalent (BE) for Generic drugs

3.Professional consulting service for Institutional review board and regulatory authority submission

4.SAE reporting and Pharmacovigilance monitoring

5.Other trial-related services